Pathogenic analysis of coxsackievirus A10 in rhesus macaques

Suqin Duan1, Fengmei Yang1, Yanyan Li1

  • 1Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, China.

Virologica Sinica
|July 1, 2022
PubMed

Insights

Rhesus macaques infected with Coxsackievirus A10 (CV-A10) exhibit human-like symptoms and multi-organ damage, establishing a valuable non-human primate model. This model aids in understanding CV-A10 pathogenesis and developing therapies for hand, foot, and mouth disease (HFMD).

Area of Science:

  • Virology and Immunology
  • Infectious Diseases
  • Pathogenesis Research

Background:

  • Coxsackievirus A10 (CV-A10) is a significant cause of hand, foot, and mouth disease (HFMD), pneumonia, and myocarditis.
  • Existing animal models offer limited insight into CV-A10 pathogenesis and human responses.
  • Human infection characteristics, replication, and shedding patterns of CV-A10 are largely unknown.

Purpose of the Study:

  • To establish and characterize a non-human primate model for CV-A10 infection.
  • To investigate the clinical symptoms, viral shedding, and pathological changes in rhesus macaques.
  • To evaluate the utility of this model for studying CV-A10 pathophysiology and potential human therapies.

Main Methods:

  • Rhesus macaques were infected with CV-A10 via respiratory or digestive routes.
  • Clinical symptoms, viral shedding, viremia, and pathological changes were monitored during acute (1-11 days post-infection) and recovery (12-180 days post-infection) phases.
  • Inflammatory responses, serum cytokines, neutralizing antibodies, and glucose levels were analyzed.

Main Results:

  • Infected macaques displayed viremia and clinical symptoms comparable to human HFMD.
  • Significant multi-organ inflammatory damage was observed in the lungs, heart, liver, and kidneys.
  • Hyperglycemia occurred during the recovery phase due to inflammatory factors, with no significant route-dependent differences.

Conclusions:

  • Rhesus macaques provide the first non-human primate model that accurately mimics CV-A10 pathophysiology in humans.
  • This model is suitable for investigating CV-A10 infection dynamics and evaluating therapeutic interventions.
  • The study highlights the potential for severe pathological outcomes and metabolic disturbances following CV-A10 infection.

Related Concept Videos